Month: October 2024
-
Thrombectomy Does Not Improve Outcomes for Patients with Large Strokes
Treatment with endovascular thrombectomy did not significantly improve outcomes after 90 days in patients with a large core stroke, as compared to patients who received standard stroke care alone, according to a recent clinical trial published in JAMA.
-
Delayed Antibody Treatment May Improve Efficacy of mRNA Vaccines
Investigators led by Pablo Penaloza-MacMaster, PhD, associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination significantly improved vaccine efficacy in mice, according to findings published in The Journal of Clinical Investigation.
-
Bonow Honored as Distinguished Scientist by American Heart Association
Robert Bonow, MD, the Max and Lilly Goldberg Distinguished Professor of Cardiology and a leading authority on valvular heart disease, has been named a 2024 Distinguished Scientist by the American Heart Association.
-
Little-Studied RNA Might be Key to Regulating Genetic Disorders Like Epilepsy, Autism
Scientists have discovered an RNA that controls how much or how little protein is produced by a gene, with implications for neurodevelopmental disorders like epilepsy and autism.
-
Study Identifies Potential Therapeutic Target for PTSD
Targeting a specific neural circuit through noninvasive neuromodulation may reduce symptoms in patients with posttraumatic stress disorder (PTSD), according to a recent study published in Nature Neuroscience.
-
Feinberg Celebrates 100 Years of The Journal of Clinical Investigation
Investigators from Feinberg School of Medicine and fellow academic and research institutions celebrated the 100-year anniversary of The Journal of Clinical Investigation during a day-long symposium in the Hughes Auditorium on October 18.
-
Youth Opioid Overdoses Spiked During Pandemic, Study Finds
Youth opioid overdoses have risen since the pandemic, according to a study analyzing nationwide EMS encounters recently published in JAMA.
-
Bridging Generational Differences at Medical Education Day
Faculty, staff, trainees and students came together to share educational research and best teaching practices during Feinberg’s 14th annual Medical Education Day on October 15.
-
Understanding How Deadly Lung Cancers Control the Local Immune System
Northwestern Medicine scientists have discovered how a protein in a deadly type of lung cancer can control how the immune system responds to the tumor, according to a study published in the Proceedings of the National Academy of Sciences.
-
Improving the Science and Treatment of Glioblastoma
The average length of survival for glioblastoma has failed to improve since it was first identified in scientific literature nearly 100 years ago. Despite this, scientists at Feinberg remain steadfast in their commitment to improving the understanding and treatment of glioblastoma through rigorous research initiatives and clinical trials.
